120 related articles for article (PubMed ID: 26293786)
1. Detection of Acanthamoeba on the ocular surface in a Spanish population using the Schirmer strip test: pathogenic potential, molecular classification and evaluation of the sensitivity to chlorhexidine and voriconazole of the isolated Acanthamoeba strains.
Rocha-Cabrera P; Reyes-Batlle M; Martín-Navarro CM; Dorta-Gorrín A; López-Arencibia A; Sifaoui I; Martínez-Carretero E; Piñero JE; Martín-Barrera F; Valladares B; Lorenzo-Morales J
J Med Microbiol; 2015 Aug; 64(8):849-853. PubMed ID: 26293786
[TBL] [Abstract][Full Text] [Related]
2. Presence of Acanthamoeba in the ocular surface in a Spanish population of contact lens wearers.
Rodríguez-Martín J; Rocha-Cabrera P; Reyes-Batlle M; López-Arencibia A; Sifaoui I; Rizo-Liendo A; Bethencourt-Estrella CJ; Piñero JE; Lorenzo-Morales J
Acta Parasitol; 2018 Jun; 63(2):393-396. PubMed ID: 29654681
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the sensitivity to chlorhexidine, voriconazole and itraconazole of T4 genotype Acanthamoeba isolated from Mexico.
Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Vanzzini-Zago V; Ramírez-Flores E; Sifaoui I; Piñero JE; Lorenzo-Morales J; Omaña-Molina M
Exp Parasitol; 2019 Feb; 197():29-35. PubMed ID: 30648558
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.
Cabello-Vílchez AM; Martín-Navarro CM; López-Arencibia A; Reyes-Batlle M; Sifaoui I; Valladares B; Piñero JE; Lorenzo-Morales J
Parasitol Res; 2014 Feb; 113(2):755-9. PubMed ID: 24265059
[TBL] [Abstract][Full Text] [Related]
5. The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain.
Martín-Navarro CM; Lorenzo-Morales J; Cabrera-Serra MG; Rancel F; Coronado-Álvarez NM; Piñero JE; Valladares B
J Med Microbiol; 2008 Nov; 57(Pt 11):1399-1404. PubMed ID: 18927419
[TBL] [Abstract][Full Text] [Related]
6. Acanthamoeba keratitis in Mexico: Report of a clinical case and importance of sensitivity assays for a better outcome.
Omaña-Molina M; Vanzzini-Zago V; Hernández-Martínez D; Reyes-Batlle M; Castelan-Ramírez I; Hernández-Olmos P; Salazar-Villatoro L; González-Robles A; Ramírez-Flores E; Servín-Flores C; Flores-Alvarado V; Alcántara-Castro M; Lorenzo-Morales J
Exp Parasitol; 2019 Jan; 196():22-27. PubMed ID: 30472333
[TBL] [Abstract][Full Text] [Related]
7. Isolation and genotyping of acanthamoeba strains from soil sources from Jamaica, West Indies.
Todd CD; Reyes-Batlle M; Martín-Navarro CM; Dorta-Gorrín A; López-Arencibia A; Martínez-Carretero E; Piñero JE; Valladares B; Lindo JF; Lorenzo-Morales J
J Eukaryot Microbiol; 2015; 62(3):416-21. PubMed ID: 25393552
[TBL] [Abstract][Full Text] [Related]
8. Isolation and genotyping of Acanthamoeba strains (T4, T9, and T11) from amoebic keratitis patients in Iran.
Hajialilo E; Behnia M; Tarighi F; Niyyati M; Rezaeian M
Parasitol Res; 2016 Aug; 115(8):3147-51. PubMed ID: 27102637
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of voriconazole anti-Acanthamoeba polyphaga in vitro activity, rat cornea penetration and efficacy against experimental rat Acanthamoeba keratitis.
Gueudry J; Le Goff L; Compagnon P; Lefevre S; Colasse E; Aknine C; Duval F; François A; Razakandrainibe R; Ballet JJ; Muraine M; Favennec L
J Antimicrob Chemother; 2018 Jul; 73(7):1895-1898. PubMed ID: 29596605
[TBL] [Abstract][Full Text] [Related]
10. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of
Padzik M; Baltaza W; Conn DB; Szaflik JP; Chomicz L
Ann Agric Environ Med; 2018 Dec; 25(4):725-731. PubMed ID: 30586959
[TBL] [Abstract][Full Text] [Related]
11. Genotyping of Acanthamoeba isolates from corneal scrapings and contact lens cases of Acanthamoeba keratitis patients in Osaka, Japan.
Abe N; Kimata I
Jpn J Infect Dis; 2010 Jul; 63(4):299-301. PubMed ID: 20657076
[No Abstract] [Full Text] [Related]
12. Molecular characterization of Acanthamoeba strains isolated from domestic dogs in Tenerife, Canary Islands, Spain.
Valladares M; Reyes-Batlle M; Martín-Navarro CM; López-Arencibia A; Dorta-Gorrín A; Wagner C; Martínez-Carretero E; Piñero JE; Valladares B; Lorenzo-Morales J
Arch Microbiol; 2015 Jun; 197(5):639-43. PubMed ID: 25716077
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of Acanthamoeba isolated from amebic keratitis related to orthokeratology lens overnight wear.
Lee SJ; Jeong HJ; Lee JE; Lee JS; Xuan YH; Kong HH; Chung DI; Ock MS; Yu HS
Korean J Parasitol; 2006 Dec; 44(4):313-20. PubMed ID: 17170573
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of Acanthamoeba strains from soil samples in Gran Canaria, Canary Islands, Spain.
Reyes-Batlle M; Todd CD; Martín-Navarro CM; López-Arencibia A; Cabello-Vilchez AM; González AC; Córdoba-Lanús E; Lindo JF; Valladares B; Piñero JE; Lorenzo-Morales J
Parasitol Res; 2014 Apr; 113(4):1383-8. PubMed ID: 24449449
[TBL] [Abstract][Full Text] [Related]
15. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
Lorenzo-Morales J; Morcillo-Laiz R; Martín-Navarro CM; López-Vélez R; López-Arencibia A; Arnalich-Montiel F; Maciver SK; Valladares B; Martínez-Carretero E
Cont Lens Anterior Eye; 2011 Apr; 34(2):83-6. PubMed ID: 21130679
[TBL] [Abstract][Full Text] [Related]
16. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
[TBL] [Abstract][Full Text] [Related]
17. Isolation and identification of pathogenic Acanthamoeba strains in Tenerife, Canary Islands, Spain from water sources.
Lorenzo-Morales J; Ortega-Rivas A; Foronda P; Martínez E; Valladares B
Parasitol Res; 2005 Mar; 95(4):273-7. PubMed ID: 15678350
[TBL] [Abstract][Full Text] [Related]
18. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
Talbott M; Cevallos V; Chen MC; Chin SA; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
Cornea; 2019 Oct; 38(10):1309-1313. PubMed ID: 31306283
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the in vitro activity of commercially available moxifloxacin and voriconazole eye-drops against clinical strains of Acanthamoeba.
Martín-Navarro CM; López-Arencibia A; Arnalich-Montiel F; Valladares B; Piñero JE; Lorenzo-Morales J
Graefes Arch Clin Exp Ophthalmol; 2013 Sep; 251(9):2111-7. PubMed ID: 23686225
[TBL] [Abstract][Full Text] [Related]
20. In-vitro development of an effective treatment for Acanthamoeba keratitis.
Ortillés Á; Belloc J; Rubio E; Fernández MT; Benito M; Cristóbal JÁ; Calvo B; Goñi P
Int J Antimicrob Agents; 2017 Sep; 50(3):325-333. PubMed ID: 28709990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
